Zimmer Biomet (NYSE:ZBH) subsidiary Cayenne Medical buried the hatchet with MedShape after a patent review board found the terms of its soft tissue anchor patent to be “indefinite.” Cayenne sued MedShape in 2014, alleging infringement by MedShape’s ExoShape device of 2 of its patents covering the AperFix soft tissue anchor. The lawsuit, filed in the U.S. District Court for Arizona, […]
Zimmer Biomet (NYSE:ZBH) said today that it closed its buyout of Cayenne Medical and its soft tissue reconstruction devices for an unspecified amount. Scottsdale, Ariz.-based Cayenne makes devices for knee and shoulder repair, including the AperFix II, CrossFix II and iFix knee ligament reconstruction and meniscal repair devices and the Quattro device for rotator cuff and labral repairs. When it […]
Zimmer Biomet (NYSE:ZBH) said today it inked a deal to buy Scottsdale, Ariz.-based soft-tissue reconstruction company Cayenne Medical. Warsaw, Ind.-based Zimmer Biomet did not release any financial details of the transaction, but said that it expects the acquisition to close during the 2nd quarter of 2016. “As a market leader in musculoskeletal healthcare, the expansion of […]
Cayenne Medical filed a lawsuit against rival MedShape Inc., alleging infringement of 2 of its patents covering its AperFix soft tissue anchor by MedShape’s ExoShape device.
The lawsuit, filed in the U.S. District Court for Arizona, alleges that MedShape hired former Cayenne salespeople with knowledge of the 2 patents at issue, which cover Cayenne’s AperFix device.
Cayenne Medical is $1 million away from reaching its $6 million fundraising goal, according to a regulatory filing.
Scottsdale, Ariz.-based Cayenne Medical makes medical devices used in knee and shoulder reconstruction surgeries.
Nine unnamed investors ponied up a collective $5 million in the equity and options sale, according to the filing.
The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.
Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.